Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Comment by dt_coreon Feb 01, 2023 9:44pm
191 Views
Post# 35261250

RE:THNK Stock Price

RE:THNK Stock PriceLooking at the Level 2 quotes there appeared to be a relatively large seller, about 1mm shares in total, that has been disposing mostly at 30 cents. That wall has largely been taken down. That's the problem with illiquid stocks, whenever a large seller wants out especially if they aren't overly sensitive to the price (think a large institutional investor where THNK is a small % of their holdings) then they just want it off their books and are happy to take the tax loss. Of course on the flip side if the company posts some good news regarding a digital client win or an earnings pre-release with good numbers then we could see the stock spike very quickly, especially considering that markets overall have been in recovery mode. The wild card has been the dilution factor if the company needs additional capital to satisfy its short term obligations. Based on management comments last quarter, they don't expect to issue many more shares to satisfy those obligations and may instead satisfy them in cash (which would really alleviate investor concerns).
<< Previous
Bullboard Posts
Next >>